HeartWare (HTWR +1.9%) moves higher after an FDA panel says it will review the Premarket...

|By:, SA News Editor

HeartWare (HTWR +1.9%) moves higher after an FDA panel says it will review the Premarket Approval application for the company's Ventricular Assist System on April 25. Leerink Swann says the overhang in the shares has been removed following the news, and it believes a Q3 approval and launch is likely.